Based on the previous studies, the first line drug simvastatin and fibrates could not reduce the high-fat diet-induced hyperlipidemia and the progress of atherosclerosis in apoE(-/-) mice (Yin et al., 2019; Yang et al., 2021). This evidence concerns the gene APOE and atherosclerosis.